Skip to main content
Aarti Pharmalabs Limited logo

Aarti Pharmalabs Limited — Investor Relations & Filings

Ticker · AARTIPHARM ISIN · INE0LRU01027 LEI · 335800TTAKRBNDK5P363 BSE.NS Manufacturing
Open in API
Filings indexed 246 across all filing types
Latest filing 2024-05-13 Capital/Financing Update
Country IN India
Listing BSE.NS AARTIPHARM

About Aarti Pharmalabs Limited

https://www.aartipharmalabs.com/

Aarti Pharmalabs Limited is a manufacturer of Active Pharmaceutical Ingredients (APIs), pharmaceutical intermediates, and xanthine derivatives. The company specializes in the development and production of complex chemistry-based products for the global pharmaceutical and generic drug industries. Its core portfolio includes APIs across diverse therapeutic areas such as oncology, cardiovascular, and anti-diabetics. Additionally, the company is a major producer of xanthines, including caffeine and theophylline. Aarti Pharmalabs offers comprehensive Contract Development and Manufacturing Organization (CDMO) services, leveraging its integrated research and development capabilities and large-scale manufacturing facilities. The organization maintains high regulatory standards, ensuring compliance with international quality benchmarks to serve a global clientele.

Recent filings

Filing Released Lang Actions
ESOP/ESOS/ESPS
Capital/Financing Update Classification · 100% confidence The document is an official communication addressed to stock exchanges (BSE and NSE) regarding the grant of stock options under a Performance Stock Option Plan (PSOP 2023). It details the number of options granted, exercise price, vesting period, and other terms related to employee stock options. The document references compliance with SEBI regulations and is an announcement of a capital-related event (grant of stock options). It is not a financial report, earnings release, or management discussion. It is also not a report publication announcement or certification. The content fits best under Capital/Financing Update (CAP) as it relates to changes in capital structure through stock options granted to employees.
2024-05-13 English
Disclosure under SEBI Takeover Regulations
Major Shareholding Notification Classification · 95% confidence The document is a declaration under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. It confirms that no encumbrance has been made on the shares by promoters or promoter group members during the financial year 2023-24. The document includes a list of promoters and promoter group members as an annexure. This is a regulatory compliance filing related to shareholding and encumbrance disclosures, not a financial report, earnings release, or management discussion. It is a formal notification to stock exchanges and regulators about shareholding status, fitting the category of Major Shareholding Notification (MRQ).
2024-05-07 English
Disclosure under SEBI Takeover Regulations
Major Shareholding Notification Classification · 95% confidence The document is a declaration under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. It confirms that no encumbrance has been made on the shares by promoters or promoter group members during the financial year 2023-24. The document includes a list of promoters and promoter group members as an annexure. This type of filing is a notification related to shareholding and encumbrance status, which fits the category of Major Shareholding Notification (MRQ). The document is not a full financial report, audit, or management report, nor is it an announcement of voting results or a regulatory compliance filing. It is a formal declaration about shareholding status under a specific regulatory provision, which aligns with MRQ filings.
2024-05-07 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 90% confidence The document is a notification letter addressed to stock exchanges about an upcoming Earnings Conference Call scheduled to discuss the company's Q4-FY24/FY24 financial results. It includes details such as date, time, dial-in numbers, and management participants. The document does not contain actual financial data or results but serves as an invitation and announcement of the call. According to the classification rules, such a document is best classified as a Call Transcript (CT) category if it contained the full transcript, but since this is only an invitation to the call, it is an announcement related to the earnings call. However, there is no specific category for 'Earnings Call Invitation' distinct from Call Transcript. The closest and most appropriate category is Call Transcript (CT) because it relates directly to the earnings call event. Confidence is high as the document clearly states it is an earnings conference call invitation and does not contain financial results or other report types.
2024-05-04 English
Board Meeting — AARTI PHARMALABS LIMITED has informed the Exchange about Board Meeting to be held on 13-May-2024 to consider and approve the Yearly Audited Financial results of the Company for the pe…
Regulatory Filings
2024-05-04 English
Board Meeting — Financial Results/Dividend/Other business matters
Board/Management Information Classification · 95% confidence The document is a formal letter addressed to stock exchanges notifying them of an upcoming Board Meeting scheduled for May 13, 2024. The agenda includes consideration and approval of audited financial results and statements for the quarter and year ended March 31, 2024, and recommendation of a final dividend. The letter references Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosures about board meetings. The document is an announcement of a board meeting and not the actual financial report or results. It is also short (1579 characters) and serves as a notification rather than containing substantive financial data or detailed management discussion. Therefore, it fits the category of Board/Management Information (MANG), which covers announcements of board meetings and related disclosures.
2024-05-04 English

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.